医学
药代动力学
造血细胞
人口
巨细胞病毒
移植
不利影响
内科学
药理学
免疫学
造血
人类免疫缺陷病毒(HIV)
病毒性疾病
疱疹病毒科
干细胞
生物
遗传学
环境卫生
作者
Andreas H. Groll,Johannes H. Schulte,Bülent Antmen,Christopher Fraser,Valerie Teal,Barbara Haber,Luzelena Caro,Jacqueline B. McCrea,Craig Fancourt,Mayankbhai Patel,Karsten Menzel,Cyrus Badshah
标识
DOI:10.1097/inf.0000000000004208
摘要
Administration of adult letermovir doses in this adolescent cohort resulted in exposures within adult clinical program margins and was associated with safety and efficacy similar to adults. Results support a letermovir dose of 480 mg (240 mg with CsA) in adolescent allo-HCT recipients.
科研通智能强力驱动
Strongly Powered by AbleSci AI